Jöerg Windisch
Director/Board Member at Polpharma Biologics Utrecht BV
Profile
Dr. Jöerg Windisch is a Chief Executive Officer & President at Polpharma Biologics S.A.
He is on the Board of Directors at Polpharma Biologics Utrecht BV.
Dr. Windisch was previously employed as an Independent Director by Outlook Therapeutics, Inc., a Chief Operating Officer by Affimed NV, and a Chief Science Officer by Sandoz International GmbH.
He received his doctorate degree from the University of Innsbruck.
Jöerg Windisch active positions
Companies | Position | Start |
---|---|---|
Polpharma Biologics Utrecht BV
Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Director/Board Member | 2017-07-31 |
Polpharma Biologics Group BV | Director/Board Member | - |
Former positions of Jöerg Windisch
Companies | Position | End |
---|---|---|
OUTLOOK THERAPEUTICS, INC. | Director/Board Member | 2019-07-17 |
AFFIMED N.V. | Chief Operating Officer | 2017-06-30 |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Chief Tech/Sci/R&D Officer | 2014-12-31 |
Training of Jöerg Windisch
University of Innsbruck | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AFFIMED N.V. | Health Technology |
OUTLOOK THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Polpharma Biologics Utrecht BV
Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Commercial Services |
Polpharma Biologics Group BV |
- Stock Market
- Insiders
- Jöerg Windisch